IRIS UniCatt

Biolato, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.930
AS - Asia 2.489
EU - Europa 2.241
SA - Sud America 463
AF - Africa 59
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.193
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.857
SG - Singapore 1.146
DE - Germania 589
CN - Cina 569
BR - Brasile 397
SE - Svezia 390
IT - Italia 359
VN - Vietnam 250
FR - Francia 214
GB - Regno Unito 127
IE - Irlanda 124
UA - Ucraina 115
IN - India 89
FI - Finlandia 84
ID - Indonesia 83
JP - Giappone 75
RU - Federazione Russa 71
HK - Hong Kong 52
BD - Bangladesh 42
CA - Canada 41
TR - Turchia 39
PL - Polonia 29
AR - Argentina 27
BE - Belgio 26
KR - Corea 25
ZA - Sudafrica 24
IQ - Iraq 20
NL - Olanda 17
ES - Italia 14
SA - Arabia Saudita 14
AT - Austria 13
LT - Lituania 12
PK - Pakistan 12
MX - Messico 10
CZ - Repubblica Ceca 9
IR - Iran 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
CL - Cile 7
PE - Perù 7
PH - Filippine 7
RO - Romania 7
CI - Costa d'Avorio 6
DK - Danimarca 6
DZ - Algeria 6
EC - Ecuador 6
EG - Egitto 6
GR - Grecia 6
KE - Kenya 6
VE - Venezuela 6
AU - Australia 5
JM - Giamaica 5
PY - Paraguay 5
UZ - Uzbekistan 5
EU - Europa 4
JO - Giordania 4
KG - Kirghizistan 4
MA - Marocco 4
MY - Malesia 4
NP - Nepal 4
TH - Thailandia 4
AL - Albania 3
BO - Bolivia 3
CO - Colombia 3
DO - Repubblica Dominicana 3
GE - Georgia 3
IL - Israele 3
LK - Sri Lanka 3
MD - Moldavia 3
PA - Panama 3
PT - Portogallo 3
TN - Tunisia 3
BY - Bielorussia 2
CG - Congo 2
CR - Costa Rica 2
CY - Cipro 2
HU - Ungheria 2
IS - Islanda 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
RE - Reunion 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BG - Bulgaria 1
BH - Bahrain 1
BZ - Belize 1
EE - Estonia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HT - Haiti 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
Totale 8.185
Salva come PNG Salva come JPEG
Città #
Singapore 629
San Jose 357
Ashburn 327
Chandler 322
New York 179
Dublin 124
Beijing 121
Dallas 96
Rome 91
Ho Chi Minh City 84
Hefei 82
Los Angeles 82
Lauterbourg 80
Milan 77
Jakarta 75
Tokyo 69
Jacksonville 64
Hanoi 57
Chicago 51
Frankfurt am Main 51
San Mateo 51
Nanjing 49
Munich 46
Wilmington 46
Helsinki 45
Boston 44
Cattolica 41
São Paulo 39
Hong Kong 38
Dearborn 35
Moscow 35
The Dalles 34
Santa Clara 33
Marseille 31
Princeton 28
Brussels 26
Seoul 25
Kent 24
Ann Arbor 22
Council Bluffs 21
London 21
Nürnberg 19
Woodbridge 19
Atlanta 17
Nuremberg 17
Redwood City 17
Saint Petersburg 17
Turku 17
Augusta 16
Buffalo 16
Houston 16
Paris 16
Izmir 15
Johannesburg 15
Nanchang 15
Bremen 14
Montreal 14
Seattle 14
Tianjin 14
Denver 13
Falls Church 13
Orem 12
Brooklyn 11
Changsha 11
Da Nang 11
Dhaka 11
Rio de Janeiro 11
Shanghai 11
St Louis 11
Baghdad 10
Boardman 10
Hebei 10
Kraków 10
Norwalk 10
Phoenix 10
Shenyang 10
Toronto 10
Warsaw 10
Amsterdam 9
Bexley 9
Fairfield 9
Guangzhou 9
Haiphong 9
Istanbul 9
Poplar 9
Falkenstein 8
Guarulhos 8
Kunming 8
Lawrence 8
Brasília 7
Düsseldorf 7
Goiânia 7
Lancaster 7
Mumbai 7
North Bergen 7
Palermo 7
Stockholm 7
Washington 7
Abidjan 6
Belo Horizonte 6
Totale 4.415
Salva come PNG Salva come JPEG
Nome #
A phase II study of sunitinib in advanced hepatocellular carcinoma 269
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 236
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 228
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 191
Liver transplantation in patients with alcoholic liver disease: A retrospective study 186
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 174
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 173
Vanishing-recurrent benign liver lesions 172
Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues 165
[The treatment of hepatocellular carcinoma: an update] 160
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 156
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 152
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 151
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 148
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 147
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 146
Severe giant cell arteritis associated with essential thrombocythaemia. 145
Quando e perché fermarsi nelle terapie: l’opinione del clinico e del bioeticista sui casi di HCC avanzato. 142
A novel ABCB11 variant in compound heterozygosity: BRIC2 or PFIC2? 134
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 132
Comment on "the role of endoscopic ultrasound in the evaluation of chronic mesenteric ischaemia" 130
Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia 124
Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind 123
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 120
A giant calcified hepatic mass 120
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 116
Acute HEV hepatitis: clinical and laboratory diagnosis 115
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 114
Letter to the Editor: Suboptimal performance of CAR-OLT score to predict 1-year risk of cardiovascular events after liver transplantation 113
Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves 112
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review 112
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 109
Clinical impact of comorbidities in an Italian NAFLD cohort 108
Proposal of a new evidence based definition of Early Allograft Failure to identify patients who needs early retransplant and call for a prospective external validation study 106
Ventricular thrombosis during sorafenib therapy for advanced hepatocellular carcinoma 105
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 104
Starvation hepatitis and refeeding-induced hepatitis: mechanism, diagnosis, and treatment 102
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program 101
Frequency of and reasons behind non-listing in adult patients referred for liver transplantation: Results from a retrospective study 98
Correlation of the transaminases alteration with the clinical severity of patients with COVID-19: A meta-analysis of the first global outbreak 96
A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series 95
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 93
Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties 92
Liver stiffness in the early post-liver transplant phase as a marker of acute allograft rejection 91
COMMON CLINICAL COMORBIDITIES IN AN ITALIAN NAFLD COHORT 91
Minimum platelet count threshold before invasive procedures in cirrhosis: Evolution of the guidelines 91
Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy 89
Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI 89
Fatty liver and drugs: the two sides of the same coin 87
Prognostic ability of BCLC-B subclassification in patients with hepatocellular carcinoma undergoing transarterial chemoembolization 87
ORGANIZATIONAL AND ECONOMIC ISSUES RELATED TO THE INTRODUCTION OF BOCEPREVIR IN THE TREATMENT OF PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN ITALY 85
Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach 83
ELF TEST IS A RELIABLE NON INVASIVE TEST FOR FIBROSIS IN NAFLD SUBJECTS 82
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study 81
Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review 79
FREQUENCY AND REASONS FOR NON-LISTING IN REFERRED ADULT PATIENTS FOR LIVER TRANSPLANTATION 77
SERUM SODIUM IS A PREDICTOR OF SURVIVAL FOR "INTERMEDIATE HCC" TREATED WITH TRANSARTERIAL CHEMIOEMBOLIZATION (TACE) 76
A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 76
Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all 76
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 76
Correction to: Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI (BMC Gastroenterology, (2021), 21, 1, (317), 10.1186/s12876-021-01878-3) 76
FREQUENCY OF AND REASONS BEHIND NON-LISTING IN ADULT PATIENTS REFERRED FOR LIVER TRANSPLANTATION 74
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 74
Liver transplantation for drug-induced acute liver failure 74
Steatohepatitis and type 2 diabetes mellitus are influenced by genetic susceptibility to increased intestinal permeability in patients with non-alcoholic fatty liver disease 73
Upper limits of downstaging for hepatocellular carcinoma in liver transplantation 71
Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins? 68
Severe Cholestatic Hepatitis due to Temozolomide: An Adverse Drug Effect to Keep in Mind. Case Report and Review of Literature 60
HEPATOMA ARTERIAL-EMBOLISATION PROGNOSTIC SCORE PREDICTS PROGRESSION IN HEPATOCELLULAR CARCINOMA TREATED BY RADIOFREQUENCY ABLATION PLUS TRANSARTERIAL CHEMOEMBOLIZATION 59
THE 15 AND 30 MINUTES SAMPLING OF 13C-BREATH TESTING ARE ABLE TO PREDICT SEVERE HEPATIC FIBROSIS AND SEVERITY OF LIVER DISEASE 58
FIBROSIS PROGRESSION DURING SUNITINIB THERAPY IN CIRRHOTIC PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA 56
HEPARANASE IN NASH: IS IT AN USEFUL MARKER OF FIBROGENESIS? 54
Liver functional reserve and survival after sunitinib therapy in cirrhotic patients with advanced hepatocellular carcinoma 53
Abdominal angina 43
GAPO syndrome: a comprehensive examination and review of 105 clinical cases 40
Corrigendum to "Acute hepatitis caused by a natural lipid-lowering product: When "alternative" medicine is no "alternative" at all" [J Hepatol 50 (2009) 1273-1277] (DOI:10.1016/j.jhep.2009.02.021) 33
Totale 8.297
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.322
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 0 0 0 0 13 36 7
2021/2022406 14 23 9 49 36 16 15 69 14 17 65 79
2022/20231.070 132 110 55 144 93 157 63 94 103 33 69 17
2023/2024708 48 171 26 46 34 109 45 33 13 40 47 96
2024/20251.415 31 29 125 55 107 54 42 61 204 131 310 266
2025/20263.444 567 111 270 412 536 273 621 169 283 202 0 0
Totale 8.297